Expression of MAGE-A3 in and histopathological analysis of forceps biopsy specimens of non– small-cell lung carcinoma patients

English:Non–small-cell lung cancer (NSCLC) is a type of epithelial lung cancer and associated with cigarette smoking (passive or active).Melanoma-associated antigen 3 (MAGE-A3) is widely expressed in various types of tumours, including NSCLC. This studyaimed to examine the MAGE-A3 expression in forc...

Full description

Saved in:
Bibliographic Details
Main Authors: Isnin Anang Marhana, -, Muhammad Amin, -, Gondo Mastutik, Gondo, Mokhammad Mukhlis, -
Format: Article PeerReviewed
Language:English
Indonesian
English
Indonesian
Published: Walter de Gruyter
Subjects:
Online Access:https://repository.unair.ac.id/127911/1/2%20artikel.pdf
https://repository.unair.ac.id/127911/2/2%20karil.pdf
https://repository.unair.ac.id/127911/3/2%20Turnitin.pdf
https://repository.unair.ac.id/127911/4/2%20Etik.pdf
https://repository.unair.ac.id/127911/
https://sciendo.com/article/10.2478/pneum-2023-0016
https://doi.org/10.2478/pneum-2023-0016
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universitas Airlangga
Language: English
Indonesian
English
Indonesian
Description
Summary:English:Non–small-cell lung cancer (NSCLC) is a type of epithelial lung cancer and associated with cigarette smoking (passive or active).Melanoma-associated antigen 3 (MAGE-A3) is widely expressed in various types of tumours, including NSCLC. This studyaimed to examine the MAGE-A3 expression in forceps biopsy specimens as a tumour biomarker to be used for early diagnosisand screening of lung cancer. This study was an observational, analytical study with a cross-sectional study design. The samplesize was determined based on Ronald Fisher’s classic z transformation formula, and samples were selected using consecutivesampling. The study population included 14 lung tumour patients. Samples were obtained by forceps biopsy with bronchoscopyguidance. Histopathological analysis was carried out using Giemsa staining. The expression of MAGE-A3 was determined usingRT-PCR. All data were analysed using SPSS statistics software (IBM SPSS Statistics, IBM® SPSS® Statistics is a powerfulstatistical software platform RRID: SCR_019096). In this study, there were 6 subjects (42.9%) with NSCLC adenocarcinomaand 8 subjects (57.1%) with squamous cell carcinoma. The positive MAGE-A3 expression was found in 5 (35.7%) of the totalresearch subjects, and the expression on RT-PCR analysis was at 569 bp. We found that MAGE 3 gene was mostly expressed inadenocarcinoma of NSCLC, even though there was no statistical correlation with histopathological results (P > 0.05). MAGE-A3expression in forceps biopsy specimens of NSCLC was mostly found in the adenocarcinoma type at 569 bp. Therefore, it couldbe used as a tumour biomarker for early diagnosis and screening of lung cancer.